ClinicalTrials.gov
ClinicalTrials.gov Menu

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01517477
Recruitment Status : Active, not recruiting
First Posted : January 25, 2012
Last Update Posted : March 9, 2018
Sponsor:
Information provided by (Responsible Party):
Glaukos Corporation

January 23, 2012
January 25, 2012
March 9, 2018
January 2012
June 2018   (Final data collection date for primary outcome measure)
Mean diurnal intraocular pressure (IOP) reduction of greater than or equal to 20% at month 12 vs. baseline [ Time Frame: 12 Months ]
Mean diurnal intraocular (IOP) reduction of greater than or equal to 20% at month 12 vs. baseline [ Time Frame: 12 Months ]
Complete list of historical versions of study NCT01517477 on ClinicalTrials.gov Archive Site
Mean diurnal IOP <18 mmHg at month 12 [ Time Frame: 12 months ]
Same as current
Not Provided
Not Provided
 
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
A Prospective, Randomized, Controlled Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications, Implanted With One, Two, or Three Trabecular Micro-Bypass Stents
The purpose of this study is to evaluate the safety and efficacy of the intraocular pressure (IOP) lowering effect of one, two, or three iStent devices in eyes of subjects previously on two anti-glaucoma medications.
Not Provided
Interventional
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Primary Open Angle Glaucoma (POAG)
  • Device: iStent
    Implantation of One iStent through a small temporal clear corneal incision.
  • Device: iStent
    Implantation of Two iStents through a small temporal clear corneal incision
  • Device: iStent
    Implantation of Three iStents through a small temporal clear corneal incision
  • Experimental: First Arm: One iStent
    Device: One iStent
    Intervention: Device: iStent
  • Experimental: Second Arm: Two iStents
    Device: Two iStent devices
    Intervention: Device: iStent
  • Experimental: Third Arm: Three iStents
    Device: Three iStent devices
    Intervention: Device: iStent
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
251
120
December 2018
June 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed with primary open-angle glaucoma (POAG)
  • Subject on two topical hypotensive medications

Exclusion Criteria:

  • Traumatic, uveitic, neovascular, or angle closure glaucoma
  • Fellow eye already enrolled
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Armenia
 
 
NCT01517477
GCF-033
No
Not Provided
Plan to Share IPD: Yes
Plan Description: 18 month results published in Clinical Ophthalmology 2015:9 2313-2320.
Glaukos Corporation
Glaukos Corporation
Not Provided
Not Provided
Glaukos Corporation
March 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP